The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in…

Overview of attention for article published in Frontiers in Psychiatry, August 2017

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 23,119 followers.

The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial,… https://t.co/xSHkTNC5EX

RT @FrontPsychiatry: The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial,… htt…

RT @FrontPsychiatry: The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial,… htt…

The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial,… https://t.co/6JeCbkHVR2

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.